Chaitanya Dutt
About
In The Last Decade
Chaitanya Dutt
17 papers receiving 348 citations
Peers
Comparison fields: 5 of 67
- Endocrinology, Diabetes and Metabolism 126
- Molecular Biology 96
- Physiology 69
- Cardiology and Cardiovascular Medicine 55
- Clinical Biochemistry 52
Countries citing papers authored by Chaitanya Dutt
This map shows the geographic impact of Chaitanya Dutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaitanya Dutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaitanya Dutt more than expected).
Fields of papers citing papers by Chaitanya Dutt
This network shows the impact of papers produced by Chaitanya Dutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaitanya Dutt. The network helps show where Chaitanya Dutt may publish in the future.
Co-authorship network of co-authors of Chaitanya Dutt
This figure shows the co-authorship network connecting the top 25 collaborators of Chaitanya Dutt. A scholar is included among the top collaborators of Chaitanya Dutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaitanya Dutt. Chaitanya Dutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries | 6 |
| 2 | TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial | 7 |
| 3 | 3 | |
| 4 | 45 | |
| 5 | 0 | |
| 6 | 26 | |
| 7 | 28 | |
| 8 | 28 | |
| 9 | 14 | |
| 10 | 7 | |
| 11 | 17 | |
| 12 | 35 | |
| 13 | 46 | |
| 14 | 30 | |
| 15 | 26 | |
| 16 | 5 | |
| 17 | 28 | |
| 18 | Randomized double-blind controlled clinical trial of serenoa repens versus placebo in the management of patients with symptomatic grade I to grade II benign prostatic hyperplasia (BPH). | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.